With significant experience in drug commercialization and the negotiation, drafting, review, and execution of transactional agreements, our firm understands the global challenges of healthcare delivery; drug pipeline development; intellectual property; data protection; merger and acquisition advisory; and multi-country market entry, market expansion, and marketing strategy.
We counsel world-class companies, trade organizations, and patients’ associations in healthcare; life sciences; biotechnology; diagnostics and therapeutics; nanotechnology; food; chemical; medical device, and pharmaceutical industries. We also advise many of the world’s most renowned mega-cap and start-up companies, hospitals, clinics, and pharmacies.
With deep grounding in European Union and United States regulatory law, business and commercial law, and data privacy, we are dedicated to supporting our clients as they innovate, develop, and market breakthrough drug therapies, medical procedures, medicinal products, and vaccines for human use – enhancing high-quality healthcare access to patients on every continent.
Comments are closed.